Swedish Pharmaceuticals & Biotech Most Popular Stocks

Xbrane Biopharma

Market Cap: SEK 362.8m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Intervacc

Market Cap: SEK 360.6m

Develops novel veterinary vaccines for animals in Sweden.

Oncopeptides

Market Cap: SEK 358.5m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

Guard Therapeutics International

Market Cap: SEK 356.0m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Promimic

Market Cap: SEK 340.1m

Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.

Lipum

Market Cap: SEK 321.4m

A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.

Cantargia

Market Cap: SEK 316.2m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

Elicera Therapeutics

Market Cap: SEK 306.3m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

AlzeCure Pharma

Market Cap: SEK 283.4m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

Karolinska Development

Market Cap: SEK 275.2m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Mendus

Market Cap: SEK 265.6m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Corline Biomedical

Market Cap: SEK 244.9m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Xintela

Market Cap: SEK 243.0m

A biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy.

Annexin Pharmaceuticals

Market Cap: SEK 220.2m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Initiator Pharma

Market Cap: SEK 216.2m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

AcuCort

Market Cap: SEK 196.7m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

Isofol Medical

Market Cap: SEK 192.0m

Operates as a clinical stage biotech company.

Medivir

Market Cap: SEK 187.1m

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.

Alzinova

Market Cap: SEK 173.0m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

Curasight

Market Cap: DKK 114.9m

A biotech company, develops treatment of cancer.

Enorama Pharma

Market Cap: SEK 150.6m

A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.

SenzaGen

Market Cap: SEK 149.9m

Provides non-animal tests for assessing allergenicity.

Biosergen

Market Cap: SEK 147.5m

A biotech company, develops antifungal products.

Alligator Bioscience

Market Cap: SEK 130.4m

A research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Finland and Sweden.

IDL Diagnostics

Market Cap: SEK 129.9m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Toleranzia

Market Cap: SEK 124.6m

A biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases.

Kancera

Market Cap: SEK 124.1m

Develops drugs for inflammatory diseases and cancer in Sweden and internationally.

Vivesto

Market Cap: SEK 121.3m

Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.

Abera Bioscience

Market Cap: SEK 111.3m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Dextech Medical

Market Cap: SEK 103.5m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

Nanologica

Market Cap: SEK 91.9m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

Coegin Pharma

Market Cap: SEK 91.1m

A biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden.

PEPTONIC medical

Market Cap: SEK 92.1m

A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.

Pila Pharma

Market Cap: SEK 80.3m

Operates as a clinical stage biotech company in Sweden.

NextCell Pharma

Market Cap: SEK 79.7m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

Biovica International

Market Cap: SEK 76.5m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.